Abre.bio

What is Abre.bio?

Abre.bio is a B2C e-commerce business based in Brazil, founded in 2021. The startup operates an online marketplace connecting consumers with products or services in the Brazilian market. With verified Stripe revenue of $154 per month and current MRR (monthly recurring revenue) of $144, Abre.bio represents an early-stage e-commerce venture available for acquisition.

The business generates consistent, measurable revenue through direct consumer transactions. For buyers evaluating acquisition opportunities in the e-commerce space, particularly those interested in the Brazilian market, Abre.bio presents a foundation with established payment processing infrastructure and an active customer base.

Financial Metrics and Performance

Abre.bio's verified financial data shows:

• Monthly Recurring Revenue (MRR): $144
• Verified Stripe Revenue: $154/month
• Business Age: Founded in 2021 (approximately 3+ years operating)

The startup maintains a consistent revenue baseline, indicating stable customer demand and operational execution. The alignment between Stripe-verified revenue ($154) and reported MRR ($144) demonstrates transparency in financial reporting—a key consideration for due diligence in startup acquisitions.

Asking price and revenue multiple information are not publicly disclosed. Interested buyers should contact the seller directly through TrustMRR's acquisition platform to discuss valuation and deal terms.

Market Opportunity and Acquisition Potential

Brazil's e-commerce sector continues to grow, with increasing digital payment adoption and consumer spending online. Abre.bio operates in this expanding market with an established Stripe integration, indicating professional payment processing capabilities and compliance with digital commerce standards.

Potential acquisition value may include:

• Revenue Base: Established recurring revenue provides immediate cash flow post-acquisition
• Market Positioning: Operating in Brazil's growing e-commerce market with local market knowledge and customer relationships
• Payment Infrastructure: Verified Stripe integration and payment processing setup
• Growth Potential: Early-stage revenue suggests significant runway for scaling and optimization

Buyers seeking to enter or expand in the Brazilian e-commerce market, or those looking to add a complementary B2C business to an existing portfolio, may find acquisition opportunities here. The current revenue level suggests the business is pre-scaled, offering potential acquirers room to apply growth strategies and operational improvements.

How to Evaluate Abre.bio for Acquisition

When considering Abre.bio as an acquisition target, key evaluation areas include:

• Customer Base: Size, retention rates, and lifetime value of existing customers
• Product Mix: What products or services generate the current revenue, and which have highest margins
• Growth Trajectory: Revenue trends over the past 12 months; whether revenue is stable, declining, or growing
• Operational Costs: Cost structure, gross margins, and operating expenses not reflected in MRR alone
• Technical Stack: Platform architecture, technology dependencies, and scalability limitations
• Competitive Positioning: Differentiation within the Brazilian e-commerce landscape

All financial data for Abre.bio is tracked and verified on TrustMRR, providing buyers with transparent, auditable metrics. Sellers on TrustMRR agree to share revenue verification data, reducing uncertainty in early acquisition discussions.

To contact the seller, view detailed metrics, or explore acquisition terms, visit Abre.bio's profile on TrustMRR's marketplace. The platform facilitates connections between founders seeking to buy startups and entrepreneurs looking to exit their businesses.